Venus Medtech (Hangzhou) Inc. (VMTHF)

Venus Medtech (Hangzhou) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	298.04	774.4	1,879	2,955	2,708
Short-Term Investments	7.67	7.24	-	-	-
Cash & Short-Term Investments	305.7	781.64	1,879	2,955	2,708
Cash Growth	-60.89%	-58.41%	-36.40%	9.12%	12.22%
Accounts Receivable	198.57	290.61	303.39	302.1	231.03
Other Receivables	-	164.44	80.75	53.8	44.55
Receivables	307.13	455.05	384.14	355.89	275.58
Inventory	98.06	112.94	104.4	90.52	59.9
Prepaid Expenses	-	0.28	1.07	1.02	0.78
Other Current Assets	91.58	258.17	99.93	36.98	316
Total Current Assets	802.48	1,608	2,469	3,440	3,360
Property, Plant & Equipment	522.11	693.47	461.28	250.75	100.01
Long-Term Investments	414.59	510	477.08	569.53	108.99
Goodwill	1,040	1,024	1,239	519.71	487.32
Other Intangible Assets	439.72	551.02	611.17	304.74	233
Long-Term Deferred Tax Assets	24.47	17.66	9.94	8.17	1.16
Other Long-Term Assets	6.76	9.15	15.86	16.93	27.32
Total Assets	3,250	4,414	5,283	5,109	4,318
Accounts Payable	30.23	33.86	9.13	8.75	5.3
Accrued Expenses	-	35.12	44.91	41.71	37.5
Short-Term Debt	17.52	136.83	100.12	0.5	-
Current Portion of Long-Term Debt	-	320.14	122.49	4.4	-
Current Portion of Leases	38.59	37.72	23.46	17.73	11.09
Current Income Taxes Payable	0.06	2.16	5.01	0.48	-
Current Unearned Revenue	3.21	29.54	4.32	17.84	16.49
Other Current Liabilities	272.14	209.79	182.68	117.13	335.15
Total Current Liabilities	361.75	805.17	492.1	208.53	405.52
Long-Term Debt	265.46	248.93	573.38	-	-
Long-Term Leases	47.53	82.56	80.2	48.15	21.67
Long-Term Unearned Revenue	-	1.63	0.6	-	1.06
Long-Term Deferred Tax Liabilities	-	17.78	17.41	53.45	32.94
Other Long-Term Liabilities	363.94	338.31	487.83	167.48	-
Total Liabilities	1,039	1,494	1,652	477.61	461.19
Common Stock	441.01	441.01	441.01	441.01	422.97
Additional Paid-In Capital	-	5,112	5,112	5,112	3,939
Retained Earnings	-	-2,882	-2,178	-1,120	-746.72
Treasury Stock	-	-72.55	-72.55	-72.55	-
Comprehensive Income & Other	1,770	321.72	305.18	185.25	200.19
Total Common Equity	2,211	2,921	3,608	4,546	3,815
Minority Interest	-	-1.3	23.45	86.21	41.61
Shareholders' Equity	2,211	2,919	3,631	4,632	3,857
Total Liabilities & Equity	3,250	4,414	5,283	5,109	4,318
Total Debt	369.09	826.19	899.64	70.78	32.76
Net Cash (Debt)	-63.39	-44.55	979.79	2,884	2,675
Net Cash Growth	-	-	-66.03%	7.81%	18.02%
Net Cash Per Share	-0.14	-0.10	2.24	6.58	6.54
Filing Date Shares Outstanding	441.01	437.9	437.9	437.9	422.97
Total Common Shares Outstanding	441.01	437.9	437.9	437.9	422.97
Working Capital	440.73	802.9	1,977	3,231	2,955
Book Value Per Share	5.01	6.67	8.24	10.38	9.02
Tangible Book Value	731.74	1,345	1,758	3,721	3,095
Tangible Book Value Per Share	1.66	3.07	4.01	8.50	7.32
Machinery	-	170.96	147.48	83.65	53.7
Construction In Progress	-	394.6	162.14	54.89	22.98
Leasehold Improvements	-	96.62	91.21	44.26	19.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.